IART - Company ID 0000917520
The table below shows INTEGRA LIFESCIENCES HOLDINGS CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.61B | $1.54B | $1.56B | $1.54B | $1.37B |
| Cost of revenue | $803.63M | $728.47M | $656.84M | $587.36M | $597.81M | $520.83M |
| Gross profit | - | - | - | - | - | $851.03M |
| R&D | - | - | - | - | - | - |
| SG&A |
INTEGRA LIFESCIENCES HOLDINGS CORP reported annual revenue of $1.64B for fiscal year 2025. That is up 1.5% from $1.61B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $992.08M (FY 2016) to $1.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $699.70M |
| $716.98M |
| $656.64M |
| $616.32M |
| $637.45M |
| $594.53M |
| Operating income | -$493.37M | $28.41M | $111.53M | $238.92M | $197.23M | $151.37M |
| Income tax | -$47.03M | -$11.29M | $13.33M | $33.34M | $45.60M | -$40.37M |
| Net income | -$516.80M | -$6.90M | $67.70M | $180.60M | $169.10M | $133.89M |
| EPS (diluted) | -$6.74 | -$0.09 | $0.84 | $2.16 | $1.98 | $1.57 |